Viewing Study NCT00396357


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2025-12-31 @ 1:01 AM
Study NCT ID: NCT00396357
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2006-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CLAF237A23104
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: External Affairs
Old Organization: Novartis Pharmaceuticals

Collaborators